Diagnostic Efficiency of Three Fully Automated Serology Assays and Their Correlation with a Novel Surrogate Virus Neutralization Test in Symptomatic and Asymptomatic SARS-COV-2 Individuals
Open Access
- 25 January 2021
- journal article
- research article
- Published by MDPI AG in Microorganisms
- Vol. 9 (2), 245
- https://doi.org/10.3390/microorganisms9020245
Abstract
To support the deployment of serology assays for population screening during the COVID-19 pandemic, we compared the performance of three fully automated SARS-CoV-2 IgG assays: Mindray CL-900i® (target: spike [S] and nucleocapsid [N]), BioMérieux VIDAS®3 (target: receptor-binding domain [RBD]) and Diasorin LIAISON®XL (target: S1 and S2 subunits). A total of 111 SARS-CoV-2 RT-PCR- positive samples collected at ≥ 21 days post symptom onset, and 127 pre-pandemic control samples were included. Diagnostic performance was assessed in correlation to RT-PCR and a surrogate virus-neutralizing test (sVNT). Moreover, cross-reactivity with other viral antibodies was investigated. Compared to RT-PCR, LIAISON®XL showed the highest overall specificity (100%), followed by VIDAS®3 (98.4%) and CL-900i® (95.3%). The highest sensitivity was demonstrated by CL-900i® (90.1%), followed by VIDAS®3 (88.3%) and LIAISON®XL (85.6%). The sensitivity of all assays was higher in symptomatic patients (91.1–98.2%) compared to asymptomatic patients (78.4–80.4%). In correlation to sVNT, all assays showed excellent sensitivities (92.2–96.1%). In addition, VIDAS®3 demonstrated the best correlation (r = 0.75) with the sVNT. The present study provides insights on the performance of three fully automated assays, which could help diagnostic laboratories in the choice of a particular assay according to the intended use.Keywords
Funding Information
- Qatar National Research Fund (RRC-2-032)
- Qatar University (QUERG-CMED-2020-2)
This publication has 44 references indexed in Scilit:
- Comparative Serological Study for the Prevalence of Anti-MERS Coronavirus Antibodies in High- and Low-Risk Groups in QatarJournal of Immunology Research, 2019
- Dengue and chikungunya seroprevalence among Qatari nationals and immigrants residing in QatarPLOS ONE, 2019
- Performance of four diagnostic assays for detecting herpes simplex virus type 2 antibodies in the Middle East and North AfricaJournal of Clinical Virology, 2019
- Herpes Simplex Virus Type 2 Seroprevalence Among Different National Populations of Middle East and North African MenSexually Transmitted Diseases, 2018
- Prevalence and molecular profiling of Epstein Barr virus (EBV) among healthy blood donors from different nationalities in QatarPLOS ONE, 2017
- Estimating seroprevalence of herpes simplex virus type 1 among different Middle East and North African male populations residing in QatarJournal of Medical Virology, 2017
- MERS-CoV Antibody Responses 1 Year after Symptom Onset, South Korea, 2015Emerging Infectious Diseases, 2017
- Seroprevalence of hepatitis E virus among blood donors in Qatar (2013‐2016)Transfusion, 2017
- Prevalence of anelloviruses (TTV, TTMDV, and TTMV) in healthy blood donors and in patients infected with HBV or HCV in QatarVirology Journal, 2016
- Index for rating diagnostic testsCancer, 1950